GLP Watchdog

MEDVi vs SkinnyRx

MEDVi has an open FDA warning letter dated February 20, 2026. SkinnyRx has an open FDA warning letter dated February 20, 2026. No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

MEDVi / SkinnyRx

MEDVi logo

MEDVi

7.7/10

Featured pick (affiliate partner)

SkinnyRx logo

SkinnyRx

6.3/10

FDA warning letters
Pharmacy
None named in our record
Lowest standing price
$199/moCompounded semaglutide injection
$248/moBrand-name semaglutide pill
States
All 50 states
47 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit MEDVi
Visit SkinnyRx

SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. MEDVi pays us nothing. The scores are computed the same way for both and are shown as computed (MEDVi 7.7, SkinnyRx 6.3). How we are paid

What the record shows

  1. 01

    MEDVi has an open FDA warning letter dated February 20, 2026. SkinnyRx has an open FDA warning letter dated February 20, 2026.

  2. 02

    MEDVi names three pharmacies, all 503A. SkinnyRx names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.

  4. 04

    Only SkinnyRx lists a price for compounded tirzepatide injection, brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    MEDVi covers three states SkinnyRx does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

MEDVi

SkinnyRx

Compounded semaglutide injection

$199/mo

$2,388 a year

$99/mo

first month only; not compared

Compounded tirzepatide injection
Not sold or not priced

$99/mo

first month only; not compared

Brand-name semaglutide pen
Not sold or not priced

$1,400/mo

$16,800 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,400/mo

$16,800 a year

Compounded oral semaglutide
Not sold or not priced

$149/mo

first month only; not compared

Compounded oral tirzepatide
Not sold or not priced

$199/mo

first month only; not compared

Brand-name semaglutide pill
Not sold or not priced

$248/mo

$2,976 a year

Foundayo (orforglipron) pill
Not sold or not priced

$248/mo

$2,976 a year

Price includes
Medication, clinician visits, shipping, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None; billed monthly
None stated; subscriptions auto-renew until canceled at least 5 days before the renewal date
Refunds
Full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed
Full refund before a provider completes the prescription review; no refunds for partially used subscription periods
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. MEDVi: October 25, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for MEDVi

7.7/10
  • Names its compounding pharmacy
  • Open FDA warning letter, February 20, 2026
Visit MEDVi

The case for SkinnyRx

6.3/10
Featured pick (affiliate partner)
  • Sells compounded tirzepatide injection and brand-name semaglutide pen, which MEDVi does not price
  • Open FDA warning letter, February 20, 2026
  • Names no compounding pharmacy
Visit SkinnyRx

Scores

MEDVi 7.7 · SkinnyRx 6.3 out of 10. Six weighted parts.

Value25%

5.0A
vs
B
5.6

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

6.0A
vs
B
2.0

Accessibility10%

10.0A
vs
B
9.5

Support10%

8.5A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

MEDVi vs SkinnyRx: questions

MEDVi has an open FDA warning letter dated February 20, 2026. SkinnyRx has an open FDA warning letter dated February 20, 2026. Letters are matched to a seller by company, domain and address, never by a similar name.
MEDVi names three pharmacies, all 503A. SkinnyRx names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
MEDVi states you can cancel at any time; refunds: full refund if medically disqualified, or if canceled within 72 hours before any service; none for months already billed. SkinnyRx states you can cancel at any time; refunds: full refund before a provider completes the prescription review; no refunds for partially used subscription periods.
SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. MEDVi pays us nothing. The scores are computed the same way for both and are shown as computed (MEDVi 7.7, SkinnyRx 6.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks